Significados de diabetic neuropathy en inglés

Demyelination is a prominent feature in nerve biopsies of patients with diabetic neuropathy.

Signals of painful diabetic neuropathy are believed to originate in the peripheral nervous system.

The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences.

We evaluated its effects on subjective symptoms and on vibration sensation in patients with diabetic neuropathy.

It appears that the clearest benefit of lipoic acid supplementation is in patients with diabetic neuropathy.

LKB1 signaling is essential for SC-mediated axon support, a function that may be dysregulated in diabetic neuropathy.

This study suggests F wave is appropriate for the assessment of diabetic neuropathy and for therapeutic trials.

Epalrestat is the unique aldose reductase inhibitor on the market, which was mainly used for the diabetic neuropathy.

The study of diabetic neuropathy has been primarily in Europids, despite the high prevalence of diabetes in other populations.

We set out to ascertain the prevalence of diabetic neuropathy and its risk factors in the island nation of Mauritius.

These observations confirm that Goshajinkigan relieves subjective symptoms and demonstrate that it improves vibration sensation in patients with diabetic neuropathy.

Peripheral diabetic neuropathy (DPN) is a complication observed in up to half of all patients with type 2 diabetes.

The putative involvement of cerebral metabolic and microvascular disturbances, similar to those implicated in the pathogenesis of peripheral diabetic neuropathy, is discussed.

Painful diabetic neuropathy is a common complication of diabetes mellitus and can affect many aspects of life and severely limit patients' daily functions.

These observations indicate that the number of nerves with abnormal value is also available as a simple and semi-quantitative index of diabetic neuropathy.

Therefore, early detection and active treatment of hyperglycemia might prevent or at least delay the development of signs of diabetic neuropathy among elderly subjects.